Novartis AG Basel (NVS)
Novartis is a holding company. Through its subsidiaries, Co. is a multinational group of companies focusing on the research, development, manufacturing and marketing of a range of pharmaceuticals and generic medicines. Co. comprises two divisions: Innovative Medicines, which researches, develops, manufactures, distributes and sells patented pharmaceuticals; and Sandoz, which develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients, and has three franchises, Retail Generics, Anti-Infectives and Biopharmaceuticals.
Company Name: |
Novartis AG Basel |
Website: |
www.novartis.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding NVS: |
5 |
Total Market Value Held by ETFs: |
$114.70M |
Total Market Capitalization: |
$292.77B |
% of Market Cap. Held by ETFs: |
0.04% |
|
|
April 29, 2024 3:03 AM Eastern
Buy (2.60 out of 4)
8th percentile
|
|